{
    "medicine_id": "65c2aaf4ccadf6756c033db71f06f3981630c32a",
    "platform_id": "DB05225",
    "metadata": {
        "name": "Eucrisa 20 mg 1g Ointment",
        "composition": "20 mg 1g AM103",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of asthma and cardiovascular disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Results from the Phase I trial show that AM103 is safe and well tolerated at doses up to 1 000 mg per day with no evidence of significant side effects Pharmacodynamic data demonstrated a robust and statistically significant reduction of LTB4 and LTE4 in a dose dependent manner",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}